JCI-accredited hospitals · 45+ hospitals & clinics · Patients from 90+ countries · 24/7 multilingual coordination
Neurology

Spinal Muscular Atrophy

9 min read Published August 10, 2026
Overview — Spinal Muscular Atrophy

Key Takeaways

  • Spinal muscular atrophy is usually caused by changes in the SMN1 gene and leads to weakness in muscles used for movement and breathing.
  • Symptoms can appear in infancy, childhood, or later in life, and the pattern varies by SMA type and severity.
  • Diagnosis often includes a neurological exam, genetic testing, and tests to assess breathing, swallowing, and muscle function.
  • Treatment may involve disease-modifying medicines, respiratory support, nutrition planning, physical therapy, and regular follow-up.
  • Families benefit from learning the early signs of breathing or feeding problems and seeking specialist input promptly.

Spinal muscular atrophy is a genetic neuromuscular condition that affects the motor nerve cells responsible for muscle movement. Early recognition, timely diagnosis, and coordinated care can make a meaningful difference for children and adults living with SMA.

Overview

Spinal muscular atrophy, often called SMA, is a genetic condition that affects the nerve cells in the spinal cord and brainstem that control voluntary muscle movement. When these motor neurons do not function well, muscles gradually become weaker and smaller, especially those needed for sitting, walking, swallowing, and breathing.

SMA is not caused by something a parent did during pregnancy or by lifestyle choices. It is usually linked to a change in the SMN1 gene, which means the body does not make enough of a protein needed by motor neurons. The condition can appear at different ages, and that timing often helps doctors understand how it may affect day-to-day life.

For families who are planning care across borders, SMA is a condition that benefits from organized specialist assessment. Neurologists, rehabilitation teams, respiratory experts, nutrition specialists, and genetic counselors often work together so that treatment decisions are practical, coordinated, and tailored to the person’s age and needs.

Symptoms

Symptoms — Spinal Muscular Atrophy

The signs of SMA depend on the type and when the first symptoms begin. In infants, the earliest clues may be poor head control, floppy muscle tone, weak kicking, difficulty sucking or swallowing, and delayed motor milestones. Some babies may breathe with effort or have weak cries, which can prompt earlier evaluation.

In children, teens, or adults, SMA may look different. A person may notice trouble climbing stairs, rising from the floor, lifting the arms, or keeping up with peers in physical activities. Muscle weakness often affects the shoulders, hips, and trunk, and over time it can change posture or make fatigue more noticeable.

Common symptoms can include:

  • Muscle weakness, especially in the arms, legs, or trunk
  • Reduced muscle tone and smaller muscle bulk
  • Delayed motor development or loss of previously gained movement skills
  • Difficulty with feeding, chewing, or swallowing
  • Breathing weakness, frequent chest infections, or shallow breathing
  • Curvature of the spine or joint stiffness in some cases

Symptoms do not look identical in every person, and not all signs appear at once. A careful clinical review is important because early recognition can support better planning and may open the door to treatment sooner.

Causes & Risk Factors

Causes & Risk Factors — Spinal Muscular Atrophy

SMA is most commonly caused by inherited changes in the SMN1 gene. This gene normally helps produce a protein essential for motor neuron survival. When both copies of SMN1 are altered, the body cannot make enough of that protein, and motor neurons become vulnerable over time.

Another gene, SMN2, can partly influence how severe SMA becomes. People naturally have different numbers of SMN2 copies, and those copies can produce a small amount of the needed protein. In general terms, more SMN2 copies may be associated with a milder form, although the course of SMA still varies from person to person.

The main risk factor is family history of the gene change. Because SMA is inherited, parents may carry the altered gene without having symptoms themselves. Genetic counseling can help families understand recurrence risks, test results, and options for current or future pregnancies.

It is helpful to remember that SMA is not contagious and cannot be prevented by avoiding exposure. The focus is on identifying it early, understanding the gene pattern, and building a care plan that addresses mobility, breathing, nutrition, and quality of life.

Diagnosis

Diagnosis begins with a medical history and neurological examination. A doctor will look at muscle strength, tone, reflexes, motor development, and any signs that breathing or swallowing are becoming difficult. The pattern of weakness often gives an important clue, but testing is needed to confirm the diagnosis.

Genetic testing is the key test for SMA. It can identify changes in the SMN1 gene and help determine whether the condition is present. In many cases, this testing also helps define the SMA type and supports discussions about treatment options and prognosis in a more individualized way.

Depending on the person’s age and symptoms, additional assessments may be used to guide care:

  • Breathing tests to check lung function and ventilation
  • Swallowing or feeding evaluations
  • Electromyography or nerve testing in selected cases
  • Imaging or spine assessment if posture or scoliosis is a concern
  • Nutrition and growth review, especially in children

For international patients, it can be useful to bring prior genetic reports, imaging, therapy notes, and a list of current supports. This helps the specialist team avoid delays and build on previous care rather than repeating work unnecessarily.

Treatment Options

There is no single treatment that fits every person with SMA, and care is usually built around the individual’s age, symptom level, and overall health. Disease-modifying therapy has changed the outlook for many patients, especially when treatment begins early, but supportive care remains important at every stage.

Available therapies may include medicines that increase the amount or function of the SMN protein. These treatments are prescribed by specialists after reviewing the diagnosis, age, and medical history. Because these medicines are highly specific, families should speak with a neuromuscular or pediatric neurology team about whether they are appropriate.

Supportive treatment often includes:

  • Physical and occupational therapy to maintain movement and function
  • Respiratory support, such as airway clearance strategies or assisted breathing when needed
  • Feeding support and nutrition planning if swallowing is difficult
  • Orthopedic care for scoliosis, hip issues, or contractures
  • Mobility aids or adaptive equipment to improve independence and comfort

Regular follow-up matters because SMA care changes over time. A person may need different support as they grow, travel, recover from infections, or move into a new life stage. In well-coordinated centers, the goal is not only to treat the disease itself but also to reduce complications and preserve day-to-day function.

Prevention & Self-care

SMA itself cannot usually be prevented once a child inherits the gene changes, but families can take steps to plan ahead. Genetic counseling is often the most useful preventive tool for relatives who want to understand carrier status, inheritance patterns, and reproductive options.

Day-to-day self-care focuses on protecting strength, breathing, nutrition, and safety. Gentle, regular movement guided by a therapist may help preserve flexibility and comfort, while overexertion should be avoided. A stable routine for airway clearance, posture support, and feeding strategies can make daily life more manageable.

Practical self-care measures may include:

  • Keeping therapy appointments and home exercise plans consistent
  • Monitoring swallowing, hydration, and weight changes
  • Watching for signs of breathing difficulty, especially during colds
  • Maintaining vaccinations and infection-prevention habits as advised by the care team
  • Using recommended braces, seating, or assistive devices correctly

Families traveling for treatment should ask for written care instructions, emergency guidance, and contact details for follow-up. That preparation can make the return home smoother and help local doctors continue the plan if needed.

When to See a Doctor

Medical assessment should be sought if a baby is not meeting motor milestones, seems unusually floppy, has feeding difficulty, or shows breathing effort that feels out of proportion to a minor illness. In older children or adults, new or progressive weakness, frequent falls, trouble climbing stairs, or hand and arm fatigue deserve attention.

Urgent medical review is important if swallowing becomes unsafe, breathing becomes labored, or a person cannot clear secretions well. These issues do not always mean a crisis, but they do need prompt evaluation by a qualified clinician so support can be adjusted safely.

People who already have a diagnosis should keep regular neurology and respiratory follow-up even when things seem stable. SMA is best managed proactively, before small changes become larger problems. Acibadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat SMA for international patients, with coordinated care that can include neurology, rehabilitation, respiratory support, and genetic counseling.

Living With Spinal Muscular Atrophy

Living with SMA often means balancing medical care with school, work, travel, and family routines. The most helpful plans are usually the ones that are realistic, well explained, and adapted to what the person wants to do each day. Independence can look different at different ages, and assistive technology often plays a positive role in preserving it.

Emotional support matters as much as physical care. Families may benefit from counseling, patient organizations, or peer support groups that understand the challenges of a chronic neuromuscular condition. When care teams communicate clearly, people are better able to plan appointments, therapy, and follow-up from another country or across different health systems.

With modern treatment and coordinated specialist support, many people with SMA can achieve meaningful improvements in comfort, function, and daily participation. The most useful next step is a thorough evaluation by a clinician experienced in neuromuscular disorders.

Frequently asked questions

What causes spinal muscular atrophy?

Spinal muscular atrophy is usually caused by inherited changes in the SMN1 gene. These changes reduce the amount of a protein needed by motor neurons, which can lead to muscle weakness over time. A genetic test is used to confirm the diagnosis.

Can SMA appear in adults?

Yes. Although SMA is often recognized in infancy or childhood, milder forms can first become noticeable later in life. Adult-onset SMA may cause gradual weakness, fatigue, or difficulty with stairs, lifting, or balance.

Is spinal muscular atrophy the same in every patient?

No. SMA varies widely from person to person, depending on the gene pattern, age at symptom onset, and overall health. Some people mainly need monitoring and therapy, while others require more intensive respiratory or feeding support.

How is SMA diagnosed?

Doctors usually begin with a neurological examination and then confirm the condition with genetic testing. Additional tests may be used to assess breathing, swallowing, muscle function, and posture so the care plan can be more complete.

What treatments are available for SMA?

Treatment may include medicines that target SMN protein production, along with physical therapy, respiratory support, nutrition planning, and orthopedic care. The best approach depends on the person’s age, symptoms, and medical history.

When should a family seek medical help?

A family should seek medical help if a child has delayed motor milestones, feeding trouble, unusual weakness, or breathing concerns. Any sudden worsening of swallowing or breathing should be assessed promptly by a doctor.

References

  • National Institute of Neurological Disorders and Stroke
  • MedlinePlus Genetics
  • Genetic and Rare Diseases Information Center
  • World Health Organization
  • Muscular Dystrophy Association

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Keep Reading

More from the Health Library

Specialists

Related Specialists

We’re With You at Every Step

How can we help you today?

Treatments are delivered at our JCI-accredited hospitals — Acıbadem International
We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.